Hikma Pharmaceuticals Regulatory News (HIK)

1.

Name of the Issuer:

Hikma Pharmaceuticals PLC

2.

State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.2 R, (ii) a disclosure made in accordance with LR 9.8.6R(1) or (iii) a disclosure made in accordance with section 793 of the Companies Act (2006):

DTR 3.1.2 R

3.

Name of person discharging managerial responsibilities/director:

Samih Darwazah, Said Darwazah, Mazen Darwazah and Ali Al-Husry

4.

State whether notification relates to a person connected with a person discharging managerial responsibilities/ director named in 3 and identify the connected person:

Yes: Darhold Limited

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest:

Beneficial interest Darhold Limited

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares:

Ordinary Shares

7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them:

Bank Sarasin & Co Ltd (known as Bank J. Safra Sarasin Ltd from 13 June 2013)

8.

State the nature of the transaction:

Grant of a pledge over 2,000,000 Ordinary Shares in support of a loan

9.

Number of shares, debentures or financial instruments relating to shares acquired:

None

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage):

N/A

11.

Number of shares, debentures or financial instruments relating to shares disposed:

None

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage):

N/A

13.

Price per share or value of transaction:

N/A

14.

Date and place of transaction:

London, July 30, 2013

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage):

57,183,028 - 28.88 per cent.

16.

Date issuer informed of transaction:

July 30, 2013

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

17.

Date of grant

18.

Period during which or date on which exercisable

19.

Total amount paid (if any) for grant of the option

20.

Description of shares or debentures involved (class and number)

21.

Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

22.

Total number of shares or debentures over which options held following notification

23.

Any additional information

24.

Name of contact and telephone number for queries

Name of authorised official or issuer responsible for making notification

Peter Speirs, Company Secretary, Hikma Pharmaceuticals PLC

Date of notification: July 31, 2013